Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.
- DOI
- 10.3332/ecancer.2008.121
- Published
- 2008
- Container
- Ecancermedicalscience
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3332/ecancer.2008.121,
title = {Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.},
author = {Fenaux P and Mufti GJ and Hellström-Lindberg E and Santini V and Gattermann N and Sanz G and List AF and Gore SD and Seymour JF and Backstrom J and Zimmerman L and McKenzie D and Beach CL and Silverman LB},
year = {2008},
journal = {Ecancermedicalscience},
doi = {10.3332/ecancer.2008.121},
url = {https://doi.org/10.3332/ecancer.2008.121}
}RIS
TY - JOUR TI - Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update. AU - Fenaux P AU - Mufti GJ AU - Hellström-Lindberg E AU - Santini V AU - Gattermann N AU - Sanz G AU - List AF AU - Gore SD AU - Seymour JF AU - Backstrom J AU - Zimmerman L AU - McKenzie D AU - Beach CL AU - Silverman LB PY - 2008 JO - Ecancermedicalscience DO - 10.3332/ecancer.2008.121 UR - https://doi.org/10.3332/ecancer.2008.121 ER -
APA
P, F., GJ, M., E, H., V, S., N, G., G, S., AF, L., SD, G., JF, S., J, B., L, Z., D, M., CL, B., & LB, S. (2008). Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.. Ecancermedicalscience. https://doi.org/10.3332/ecancer.2008.121
Source records
- pubmed · retrieved 2026-09-26T19:54:29.705Z